Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease.

Steven G. Coca, Gregory K. Buller

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)e29; author reply e30
JournalAmerican Heart Journal
Volume148
Issue number6
StatePublished - Dec 2004

Cite this